Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Monro Muffler Brake Inc (MNRO): Hedge Funds Aren’t Crazy About It, Insider Sentiment Unchanged

Page 1 of 2

In the 21st century investor’s toolkit, there are plenty of gauges market participants can use to analyze stocks. Two of the most underrated are hedge fund and insider trading activity. At Insider Monkey, our research analyses have shown that, historically, those who follow the top picks of the best hedge fund managers can beat the market by a solid margin (see just how much).

Just as crucial, positive insider trading activity is a second way to analyze the world of equities. Obviously, there are plenty of incentives for an upper level exec to drop shares of his or her company, but only one, very clear reason why they would behave bullishly. Various empirical studies have demonstrated the impressive potential of this method if shareholders understand what to do (learn more here).

Monro Muffler Brake Inc (NASDAQ:MNRO)

What’s more, let’s discuss the recent info surrounding Monro Muffler Brake Inc (NASDAQ:MNRO).

How are hedge funds trading Monro Muffler Brake Inc (NASDAQ:MNRO)?

In preparation for the third quarter, a total of 7 of the hedge funds we track were bullish in this stock, a change of -22% from the first quarter. With the smart money’s capital changing hands, there exists a select group of key hedge fund managers who were increasing their stakes significantly.

According to our 13F database, Mariko Gordon’s Daruma Asset Management had the largest position in Monro Muffler Brake Inc (NASDAQ:MNRO), worth close to $64.3 million, accounting for 3.1% of its total 13F portfolio. Sitting at the No. 2 spot is Royce & Associates, managed by Chuck Royce, which held a $42.5 million position; 0.1% of its 13F portfolio is allocated to the stock. Some other hedge funds with similar optimism include Charles Akre’s Akre Capital Management, Mark N. Diker’s Diker Management and Mario Gabelli’s GAMCO Investors.

Since Monro Muffler Brake Inc (NASDAQ:MNRO) has experienced declining interest from the smart money’s best and brightest, logic holds that there was a specific group of fund managers who sold off their full holdings heading into Q2. Intriguingly, Ken Grossman and Glen Schneider’s SG Capital Management said goodbye to the biggest stake of the “upper crust” of funds we track, comprising close to $4.6 million in stock. Noam Gottesman’s fund, GLG Partners, also sold off its stock, about $2.3 million worth. These bearish behaviors are important to note, as total hedge fund interest was cut by 2 funds heading into Q2.

Insider trading activity in Monro Muffler Brake Inc (NASDAQ:MNRO)

Insider buying made by high-level executives is at its handiest when the company in focus has seen transactions within the past half-year. Over the latest 180-day time frame, Monro Muffler Brake Inc (NASDAQ:MNRO) has experienced zero unique insiders buying, and zero insider sales (see the details of insider trades here).

We’ll also review the relationship between both of these indicators in other stocks similar to Monro Muffler Brake Inc (NASDAQ:MNRO). These stocks are Standard Motor Products, Inc. (NYSE:SMP), Tenneco Inc (NYSE:TEN), Westport Innovations Inc. (USA) (NASDAQ:WPRT), American Axle & Manufact. Holdings, Inc. (NYSE:AXL), and Dorman Products Inc. (NASDAQ:DORM). This group of stocks are in the auto parts industry and their market caps are similar to MNRO’s market cap.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!